Perrigo Company PLC Price Target Increased to $176.00 by Analysts at Jefferies Group (PRGO)
Jefferies Group increased their price target on shares of Perrigo Company PLC (NASDAQ:PRGO) from $160.00 to $176.00 in a research note issued on Friday. The firm currently has a “buy” rating on the stock. Jefferies Group’s price objective indicates a potential upside of 17.89% from the company’s current price.
Shares of Perrigo Company PLC (NASDAQ:PRGO) opened at 149.29 on Friday. Perrigo Company PLC has a 52-week low of $115.94 and a 52-week high of $168.39. The stock’s 50-day moving average is $149.9 and its 200-day moving average is $148.. The company has a market cap of $19.975 billion and a P/E ratio of 81.94.
Perrigo Company PLC (NASDAQ:PRGO) last released its earnings data on Thursday, August 14th. The company reported $1.74 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.55 by $0.19. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. On average, analysts predict that Perrigo Company PLC will post $7.50 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 16th. Stockholders of record on Friday, August 29th will be paid a dividend of $0.105 per share. This represents a $0.42 annualized dividend and a dividend yield of 0.28%.
Other equities research analysts have also recently issued reports about the stock. Analysts at Deutsche Bank initiated coverage on shares of Perrigo Company PLC in a research note on Tuesday, July 22nd. They set a “buy” rating and a $189.00 price target on the stock. Analysts at Morgan Stanley downgraded shares of Perrigo Company PLC from an “overweight” rating to an “equal weight” rating in a research note on Friday, July 11th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $167.83.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.